Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.

Gregory KJ, Conn PJ
Mol Pharmacol. 2015 88 (1): 188-202

PMID: 25808929 · PMCID: PMC4468636 · DOI:10.1124/mol.114.097220

The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.

Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

MeSH Terms (8)

Allosteric Site Benzhydryl Compounds Central Nervous System Drug Design Humans Molecular Targeted Therapy Protein Conformation Receptors, Metabotropic Glutamate

Connections (1)

This publication is referenced by other Labnodes entities: